140 related articles for article (PubMed ID: 26892312)
1. Comparison of 3 intranasal mists for anesthetizing maxillary teeth in adults: A randomized, double-masked, multicenter phase 3 clinical trial.
Ciancio SG; Marberger AD; Ayoub F; Garlapo DA; Pantera EA; Pantera CT; Al-Mubarak S; Sobieraj BD; He DY; Myneni SR
J Am Dent Assoc; 2016 May; 147(5):339-347.e1. PubMed ID: 26892312
[TBL] [Abstract][Full Text] [Related]
2. Double-masked, randomized, placebo-controlled study to evaluate the efficacy and tolerability of intranasal K305 (3% tetracaine plus 0.05% oxymetazoline) in anesthetizing maxillary teeth.
Hersh EV; Pinto A; Saraghi M; Saleh N; Pulaski L; Gordon SM; Barnes D; Kaplowitz G; Bloom I; Sabti M; Moore PA; Lee S; Meharry M; He DY; Li Y
J Am Dent Assoc; 2016 Apr; 147(4):278-87. PubMed ID: 26822100
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a novel nasal spray for maxillary dental anesthesia.
Ciancio SG; Hutcheson MC; Ayoub F; Pantera EA; Pantera CT; Garlapo DA; Sobieraj BD; Almubarak SA
J Dent Res; 2013 Jul; 92(7 Suppl):43S-8S. PubMed ID: 23690356
[TBL] [Abstract][Full Text] [Related]
4. Anesthetic Efficacy of Intranasal 3% Tetracaine plus 0.05% Oxymetazoline (Kovanaze) in Maxillary Teeth.
Capetillo J; Drum M; Reader A; Fowler S; Nusstein J; Beck M
J Endod; 2019 Mar; 45(3):257-262. PubMed ID: 30803532
[TBL] [Abstract][Full Text] [Related]
5. Intranasal tetracaine and oxymetazoline spray for maxillary local anesthesia without injections.
Saraghi M; Hersh EV
Gen Dent; 2017; 65(2):16-19. PubMed ID: 28253176
[No Abstract] [Full Text] [Related]
6. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings.
Giannakopoulos H; Levin LM; Chou JC; Cacek AT; Hutcheson M; Secreto SA; Moore PA; Hersh EV
J Am Dent Assoc; 2012 Aug; 143(8):872-80. PubMed ID: 22855901
[TBL] [Abstract][Full Text] [Related]
7. Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles.
Hersh EV; Saraghi M; Moore PA
Curr Med Res Opin; 2016 Nov; 32(11):1919-1925. PubMed ID: 27646144
[TBL] [Abstract][Full Text] [Related]
8. Kovanaze Intranasal Spray vs Traditional Injected Anesthetics: a Study of Pulpal Blood Flow Utilizing Laser Doppler Flowmetry.
Thayer S; Townsend JA; Peters M; Yu Q; Odom M; Sabey KA
Anesth Prog; 2022 Apr; 69(1):31-38. PubMed ID: 35377931
[TBL] [Abstract][Full Text] [Related]
9. Intranasal anesthetic effects of lidocaine and tetracaine compared.
Noorily AD; Otto RA; Noorily SH
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):370-4. PubMed ID: 7567006
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of an Intranasally Administered Combination of Oxymetazoline and Tetracaine in Healthy Volunteers.
Cacek AT; Gobburu JV; Gopalakrishnan M
J Clin Pharmacol; 2017 Feb; 57(2):247-254. PubMed ID: 27436060
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis.
Meltzer EO; Bernstein DI; Prenner BM; Berger WE; Shekar T; Teper AA
Am J Rhinol Allergy; 2013; 27(2):102-8. PubMed ID: 23562197
[TBL] [Abstract][Full Text] [Related]
12. Intranasal topical local anesthetic and decongestant for flexible nasendoscopy in children: a randomized, double-blind, placebo-controlled trial.
Chadha NK; Lam GO; Ludemann JP; Kozak FK
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1301-5. PubMed ID: 24158493
[TBL] [Abstract][Full Text] [Related]
13. Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status Migrainosus.
Darsey M; Kyros T; Wang V; Rizzoli PB
Headache; 2020 Feb; 60(2):471-472. PubMed ID: 31919839
[No Abstract] [Full Text] [Related]
14. Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
Neighbors CL; Salvador CF; Zhu B; Camacho M; Tsai P
J Laryngol Otol; 2022 Jan; 136(1):8-16. PubMed ID: 34702392
[TBL] [Abstract][Full Text] [Related]
15. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours.
Druce HM; Ramsey DL; Karnati S; Carr AN
Rhinology; 2018 Dec; 56(4):343-350. PubMed ID: 29785414
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison between oral pseudoephedrine and topical oxymetazoline in the prevention of barotrauma during air travel.
Jones JS; Sheffield W; White LJ; Bloom MA
Am J Emerg Med; 1998 May; 16(3):262-4. PubMed ID: 9596428
[TBL] [Abstract][Full Text] [Related]
17. A prospective, randomized, double-blind study comparing the efficacy of topical anesthetics in nasal endoscopy.
Gaviola GC; Chen V; Chia SH
Laryngoscope; 2013 Apr; 123(4):852-8. PubMed ID: 23404424
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
Banov CH; Lieberman P;
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new administration form of oxymetazoline on maxillary ostial patency in healthy individuals and patients with acute rhinitis.
Ackerhans M; Jannert M; Tönnesson M
Acta Otolaryngol Suppl; 1994; 515():49-52. PubMed ID: 8067244
[TBL] [Abstract][Full Text] [Related]
20. Improving mucosal anesthesia for awake endotracheal intubation with a novel method: a prospective, assessor-blinded, randomized controlled trial.
Han C; Li P; Guo Z; Guo Y; Sun L; Chen G; Qiu X; Mi W; Zhang C; Berra L
BMC Anesthesiol; 2020 Dec; 20(1):301. PubMed ID: 33317460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
